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Tuberculosis, a lung disease caused by Mycobacterium tuberculosis (Mtb), is one of the
ten leading causes of death worldwide affecting mainly developing countries. Mtb can
persist and survive inside infected cells through modulation of host antibacterial attack,
i.e., by avoiding the maturation of phagosome containing mycobacteria to more acidic
endosomal compartment. In addition, bacterial phosphatases play a central role in the
interplay between host cells and Mtb. In this study, we characterized the Rv2577 of Mtb
as a potential alkaline phosphatase/phosphodiesterase enzyme. By an in vitro kinetic
assay, we demonstrated that purified Rv2577 expressed in Mycobacterium smegmatis
displays both enzyme activities, as evidenced by using the artificial substrates p-NPP
and bis-(p-NPP). In addition, a three-dimensional model of Rv2577 allowed us to define
the catalytic amino acid residues of the active site, which were confirmed by site-
directed mutagenesis and enzyme activity analysis, being characteristic of a member of
the metallophosphatase superfamily. Finally, a mutation introduced in Rv2577 reduced
the replication of Mtb in mouse organs and impaired the arrest of phagosomes
containing mycobacteria in early endosomes; which indicates Rv2577 plays a role in
Mtb virulence.
Keywords: Mycobacterium tuberculosis, virulence factor, Rv2577, phosphatase, phosphodiesterase
INTRODUCTION
Tuberculosis (TB) is an infectious disease whose etiological agent is Mycobacterium tuberculosis
(Mtb). The last report of the World Health Organization (WHO) informed that about a quarter of
the world’s population is infected with Mtb, with the consequent risk of developing TB, and that an
estimate of 10 million of new cases and 1.45 million deaths occurred in 20181. This treatable, and
1https://www.who.int/tb/publications/global_report/en/
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even curable, disease, which affects mainly developing countries,
is one of the ten leading causes of death worldwide. To date,
BCG is the available vaccine used for TB. However, BCG only
prevents young people from developing the disease and fails to
protect the adult population. Even when the total number of TB
cases has remained practically unchanged in recent years, there
has been a marked geographic imbalance in the number of new
cases because of co-infection with HIV, the emergence of multi
and extreme resistant strains to the drugs historically used and
the poor socio-economic conditions of the infected population.
Mtb has evolved to persist and survive inside host
macrophages by regulating the expression of certain virulence
factors. These factors help the bacterium to adapt physiologically
and metabolically to the hostile environment of the macrophage.
One of the most efficient strategies displayed by Mtb to counteract
the macrophage actions is to modulate the normal progression
of the phagosome-containing mycobacteria, thus preventing it
from maturing into an active phagolysosome. The modulation
of the intracellular endosomal trafficking allows virulent
mycobacteria to persist and replicate in a non-acidic niche and
to avoid its immunological detection (Forrellad et al., 2013b).
Mycobacterial phosphatases, together with complex lipids
[such as mycolic acids, sulfolipids, phthiocerol dimycocerosate
(PDIMs), trehalose-di and mono-mycolates, phosphatidyl-
myo-inositol hexamannosides (PIM6)] and lipoglycans [such
as mannose capped lipoarabinomannan (ManLAM)], play an
essential role in this modulation (Jackson, 2014).
Phosphatases are enzymes that catalyze the hydrolysis of some
phospho-substrates, including glycolysis intermediaries (fructose
1,6-biphosphate, phosphoenolpyruvate, glycerophosphate),
phosphoproteins, trehalose-6-phosphate, phosphoinositol
phosphate, nucleotides and nucleic acids. These enzymes are
classified into two large groups according to their molecular
mass: high molecular weight (HMW) of around 55 kDa and
low molecular weight (LMW) of approximately 35 kDa. The
better characterized LMW phosphatases are widely distributed
in animals, plants, fungi and prokaryotes. The broad catalog of
phosphatases in Mtb comprises protein tyrosine phosphatases
(PTP), phosphoserine phosphatases, lipid phosphatases and
phosphodiesterases (PDE). PtpA and PtpB are the unique
members within PTP and the most studied phosphatases of
Mtb (Bach et al., 2008; Beresford et al., 2009; Wong et al., 2011;
Margenat et al., 2015). On the other hand, PstP and SerB2
(Boitel et al., 2003; Wehenkel et al., 2007; arora et al., 2014) are
representatives of phosphoserine phosphatases, whereas SapM
is a lipid phosphatase (Saleh and Belisle, 2000; Vergne et al.,
2005; Fernandez-Soto et al., 2019) and CdnP and mPDE are PDE
(Shenoy et al., 2005, 2007; Dey et al., 2017). The joint action of
these enzymes is critical to the virulence of Mtb. Indeed, each
enzyme targets specific molecules that generally lead to the
inhibition of recruitment and binding of the lysosome to the
phagosome containing the mycobacteria (Beresford et al., 2009;
Puri et al., 2013; Zulauf et al., 2018).
Particularly, Rv2577 is annotated as a putative phosphatase
(Cole et al., 1998) with a protein structure homologous to that
of the eukaryotic purple acid phosphatase (PAP), mainly of
plants (Schenk et al., 2001). A previous study by our group
revealed that the expression of Mb2608, the ortholog of Mtb
Rv2577, was upregulated, both in vitro cultures and inside bovine
macrophages, in a hypervirulent Mycobacterium bovis strain, in
relation to a more attenuated M. bovis strain (Blanco et al., 2009).
Thus, Mb2608 may participate in M. bovis virulence; however, the
function of Mb2608 and Rv2577 remains mostly unknown.
With this in mind, we performed a kinetic and structural
characterization of Rv2577. Furthermore, we evaluated its role
in Mtb intracellular trafficking as well as in Mtb replication in
macrophages and a mouse model of infection, respectively.
RESULTS
Rv2577 Is an HMW Alkaline Phosphatase
and Phosphodiesterase Enzyme
The Rv2577 protein has been annotated as a conversed
hypothetical protein of unknown function according to TB
database2. A BLASTp analysis demonstrated that Rv2577 shares
about 25% of identity with PAPs of the metallophosphatase
superfamily (MPP) (Supplementary Figure 1), a family mainly
from plants, although it is also present in animals and fungi. This
is a diverse family of binuclear metallohydrolases that catalyze
the hydrolysis of many activated phosphoric acid mono- and
di-esters as well as anhydrides.
A PROSITE analysis identified a twin arginine translocation
signal (TAT-signal) in the N-terminal of Rv2577 (first 52 amino
acids) (Figure 1A). This finding suggests a cell wall location
or secretion to the extracellular medium. In addition, a Pfam
analysis demonstrated the presence of a PAP N-terminal domain
(PF16656, residues 67–150) and a Metallophos MPP_PAPs
or Calcineurin-like phosphoesterase domain (PF00149,
residues 215–513) (Figure 1A). Both domains are present in
metallophosphoesterases, such as phosphoserine phosphatases,
5′-nucleotidases, sphingomyelin phosphodiesterases, 2′,3′ and
3′,5′-cyclic-nucleotide phosphodiesterase as well as nucleases3
As mentioned above, the presence of a TAT signal peptide
suggests the secretion of Rv2577 or its localization in the cell wall.
Therefore, to investigate its subcellular location, we expressed
Rv2577 as a Hemagglutinin-Histidine (HA-His) fusion protein
(rRv2577) in the fast-growing mycobacterial Mycobacterium
smegmatis (M. smegmatis-Rv2577). Curiously, according to a
SDS-PAGE gel analysis, Rv2577 occurs in two isoforms with
different apparent molecular weights: 64.5 kDa in the cell wall
fraction and 60.2 kDa in the soluble fraction obtained in a
buffer with detergent (Figure 1B and Supplementary Figure 2).
A nano-HPLC-MS/MS analysis confirmed the presence of both
Rv2577 isoforms in the gel bands. The results allowed the
identification of 29 and 43 peptides corresponding to the Rv2577
sequence in the soluble (72% protein sequence coverage) and
cell wall fraction (92% protein sequences coverage), respectively
(Supplementary Table 1).
Even though the TAT signal sequence suggests the secretion
of rRv2577, the WB and nano-HPLC-MS/MS analyses revealed
2https://mycobrowser.epfl.ch/
3https://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi
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FIGURE 1 | Rv2577 is an HMW alkaline phosphatase and phosphodiesterase enzyme detected mainly in the cell wall of mycobacteria. (A) Scheme of the Rv2577
primary sequence with its conserved domains: the Twin arginine translocation (TAT) signal peptide (SP) (1–52 residues), the purple acid phosphatase N-terminal
domain (PAP, 67–150 residues) and the metallophos (MPP)/Calcineurin-like phosphoesterase domain (215–513 residues). According to Pfam database, these last
two domains represent the phosphatase catalytic signature. (B) Western blot (WB) analysis with α-HA antibody showing the subcellular localization of Rv2577 in the
soluble cytosolic and membrane (SF) or cell wall (CWF) fractions from M. smegmatis that overexpress the Rv2577-HA-His fusion protein (Rv2577). The same
amount of total protein was loaded per lane, separated by SDS-PAGE and then transferred for WB analysis. The arrows indicate two reactive bands of ∼ 60.2 kDa
(soluble isoform) and ∼ 64.5 kDa (cell wall isoform). M. smegmatis wild type (Ms) and M. smegmatis with the empty pML2031 vector (2013) were used as negative
controls. (C) Phosphatase activity of Rv2577 in the soluble fraction from M. smegmatis wild type (M. smegmatis) and M. smegmatis overexpressing the Rv2577
protein [M. smegmatis (Rv2577)] at 6, 7, 8, or 9 pH with p-NPP as substrate. (D) Phosphatase and phosphodiesterase activities of IMAC-Ni+2-purified rRv2577
protein (black bars) and IMAC-Ni+2 purified proteins from M. smegmatis (white bars) at 8 pH with the artificial p-NPP or bis-(p-NPP) substrates, respectively. Graphs
(C,D) represent the results obtained in three independent experiments performed in duplicate.
no detectable rRv2577 protein in the culture supernatant of
M. smegmatis (Supplementary Table 1 and ProteomeXchange
with identifier PXD019769).
We also evaluated possible post-translational modifications
that could account for the two apparent molecular weight
forms in the cell wall fraction. The analyzed post-translational
modifications included pupylation, phosphorylation and the
most common glycosylation motifs previously reported in
membrane and cell envelope proteins of Mtb (Birhanu et al.,
2019). However, none of these modifications was detectable
by nano-HPLC-MS/MS analysis (Supplementary Table 1.
ProteomeXchange with identifier PXD019769).
Subsequently, we assessed in vitro the putative enzymatic
activity of Rv2577 (soluble isoform) by evaluating its capability to
hydrolyze artificial substrates. First, we determined that Rv2577
has an optimal alkaline pH for phosphatase activity (Figure 1C).
This is similar to that of other reported prokaryotic PAPs (Yeung
et al., 2009; Rodriguez et al., 2014) but different from that of
eukaryotic PAPs, a family of enzymes with an optimal catalytic
activity at 4–7 pH.
To further characterize Rv2577, we overexpressed rRv2577
in M. smegmatis and purified it by IMAC-Ni+2. The hydrolytic
capability of rRv2577 against artificial substrates p-NPP
and bis-(p-NPP) was 36.4 and 15.6 ηmol p-NP∗min−1∗mg
protein−1, respectively (Figure 1D). This result suggests
that the phosphatase activity of Rv2577 is higher than its
phosphodiesterase activity. This higher enzymatic activity
was observed at physiological and alkaline pHs, regardless
of the tested substrate (Supplementary Figure 3). According
to a kinetic parameter analysis of rRv2577 (Table 1 and
Supplementary Figure 4) the Km of the specificity constant
kcat/Km was of a similar order for p-NPP (82µM) and bis-(p-
NPP) (60µM), whereas the kcat was 2.4 higher for p-NPP than
for bis-(p-NPP) (Table 1). Thus, Rv2577 displayed a slightly
higher kcat/Km value for p-NPP.
Altogether, these data indicate that Rv2577 is a
phosphatase, apparently an alkaline phosphatase, with
the capacity to hydrolyze both phosphomonoester and
phosphodiester substrates.
The Structural Characteristics of Rv2577
Are Similar to Those of PAPs
The three dimensional (3D) molecular modeling structure of
Rv2577 was developed with the i-tasser server (Yang and
Zhang, 2015). This analysis is based on multiple crystallographic
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TABLE 1 | Kinetic parameters values of rRv2577.





p-NPP 82 42 2.4 29.1
bis-(p-NPP) 60 17 1 16.8
The reactions were carried out in the presence of rRv2577 87.4 ηM at 8 pH and
37◦C by continuous method.
structures of related phosphatase enzymes. The best model
displayed a reasonable accuracy confidence score (C-score) of 0.7
(C-score is typically in the range of [−5, 2], where the higher
value refers to a model with a high confidence and vice-versa)
(Figure 2A). A PAP from sweet potato (PDB: 1XZW) was the
most similar structural analog, with template modeling (TM)
and root mean square deviation (RSMD) scores (Zhang and
Skolnick, 2004) of 0.84 and 0.68, respectively. The estimation
of the evolutionary conservation of residues in the protein was
assessed with the ConSurf server (Ashkenazy et al., 2016) as a
measure of their structural and functional importance.
Aligning the results from different experiments, we analyzed
the sequence of 150 analogous proteins, including the top
structure template PDB 1XZW, alkaline prokaryotic and acid
eukaryotic phosphatase enzymes. The results identified a
functional domain with highly conserved residues involved in
the metal coordination and reaction mechanism (Figures 2A,B).
Rv2577 presents a typical folding of PAPs and PDE, and
maintains the typical consensus catalytic motif for the hydrolysis
of phosphoesters. This consensus motif consists of seven
invariable amino acid residues in five conserved domains:
GDXX/GDXXY/GNH [D/E]/XXXH/GHXH (Richter, 2002).
In Rv2577, particularly, this consensus is represented as
GD173QS/GD217LCY220/GN253HE/VCMH348/GH385EH387.
These residues would interact with the phospho-substrate and
coordinate the bimetallic center Fe+3-Me +2 (where Me as Fe +2,
Mn+2, Ca+2, or Mg+2 would be the typical cations). Functional
and ligand analyses conducted by COACH predictor (within
i-tasser; by comparing with interaction complexes at PDB)
resulted in the prediction of two putative ligands: the divalent
cation Mn and 1RF ligand and the oxyphosphorane analogs at
PDBs 3RL4 and 6HWR, respectively (Figure 2B). Figure 2C
shows the overlapped Rv2577 and 1XZW 3D models, whereas
Figure 2D displays the similar arrangement of the amino acid
residues that are part of their active sites.
Based on the structural information, we performed site-
directed point mutations of D173, D217, Y220, N253, H348, H385
and H387 to determine the catalytic residues of Rv2577. These
residues in the active site were replaced by the amino-acid
alanine (Ala). All these mutants as well as the wild type rRv2577
were expressed as recombinant proteins in M. smegmatis. The
wild type rRv2577 and mutants displayed similar levels of
expression, thus indicating that Ala replacements did not affect
protein stability (Supplementary Figure 5). We then evaluated
the contribution of each amino acid residue to the hydrolytic
activity against p-NPP and bis-(p-NPP). All of the mutations
abrogated the hydrolytic activity of Rv2577 and resulted in an
enzymatic activity similar to that observed for the negative
control (Figure 2E).
These results demonstrate that the amino acids D173, D217,
Y220, N253, H348, H385 and H387 are catalytic residues that
form the active site of Rv2577; which suggests a catalytic
mechanism similar to that of PAPs and confirms the proposed
structure model.
The Mutation in the Rv2577 Gene Inhibits
the Arrest of Macrophage Maturation
According to a previous study, the Mb2608 gene, the orthologous
of Rv2577 in M. bovis, was overexpressed in a virulent M. bovis
strain in relation to an attenuated M. bovis strain (Blanco et al.,
2009). With this in mind, we evaluated the relevance of Rv2577 in
the replication of a pathogenic mycobacterium in vivo by using
an Mtb CDC 1551 transposon mutant in the MT2654 gene (the
Rv2577 ortholog) (Supplementary Table 2). The Mtb CDC 1551
wild type, the transposon mutant renamed as Mtb Rv2577 mutant
(or Rv2577-mut) and the complemented strains were used to
perform in vivo and in vitro experiments of virulence.
The interruption of Rv2577 ortholog by transposon mutation
carrying a kanamycin resistance, was confirmed by PCR analysis
(Supplementary Figure 6). Rv2577 does not seem to be part
of an operon, since the surrounding genes in the genome are
encoded in the opposite DNA strand to Rv2577. Therefore, the
transposon insertion should not have produced any polar effect in
neighboring genes. The Mtb Rv2577 mutant was complemented
with an intact copy of Rv2577 gene cloned in the mycobacterial
replicative plasmid pVV16 (Supplementary Table 2). The wild
type, mutant and complemented strains displayed similar growth
rates (Supplementary Figure 7), thus demonstrating that the
transposon insertion did not impair the in vitro bacterial growth.
In addition, in accordance with reports in M. bovis (Blanco
et al., 2009), Rv2577 gene was expressed during the in vitro
growth of Mtb in rich media and intracellularly inside human
THP-1 macrophages (Supplementary Figure 8).
One of the mechanisms whereby Mtb persists and survives
inside the phagosome is by preventing the recruitment and fusion
of lysosomes to infected phagosomes, thus inhibiting the bacterial
lysis. Major phosphatases of Mtb such as PtpA, PtpB, and SapM
block the binding between lysosome and the infected phagosomes
(Wong et al., 2011, 2013; Puri et al., 2013; Zulauf et al., 2018).
To evaluate the role of Rv2577 in the intracellular trafficking
of Mtb in the human THP-1 macrophages, we quantified
the association of the late endosomal marker LAMP-3 to
the phagosome containing the Mtb wild type, Rv2577 mutant
or complemented strains after 3 h of infection. Confocal
microscopy and immunofluorescence analyses showed higher
co-localization of Rv2577 mutant with LAMP-3 than the
wild type and complemented strains (Figure 3). Similar
impairment of phagosome arrest was detected for the Rv2577
mutant in the murine J774 macrophages, as evidenced by
higher co-localization of the mutant to the late phagosome
marker LAMP-2 (Supplementary Figure 9). However, no
significant differences were detected between the intracellular
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FIGURE 2 | Rv2577 has a similar 3D structural model than that of the purpura acid phosphatases, with similar active site residues, as well, that are critical for
catalysis. (A) The molecular model of Rv2577 based on sequences of 150 analogous proteins, including the top structure template of Ipomoea batata PAP (PDB
1XZW), alkaline prokaryotic and acid eukaryotic phosphatases. The color variation determines the degree of conservation of amino acid residues from minor (cyan) to
major (magenta). (B) The catalytic site of Rv2577 is supported by residues D173, D217, Y220, N253, H348, H385 and H387 (represented as magenta sticks) and the
divalent cations Mn+2 (blue ball) and Fe+3 (orange ball), which are part of the active site in 1XZW and are conserved in Rv2577. A phosphate group located in the
active site is also represented (green sticks). (C) Overlapping structural model of Rv2577 (magenta) and 1XZW (cyan). (D) Amino acid residues that are part of the
catalytic site based on (C). (E) The proposed model (inset) was confirmed by replacement of each catalytic residue by alanine. Phosphatase and phosphodiesterase
activities of the Rv2577 wild type (Rv2577wt) and Rv2577 mutants (D173A, D217A, Y220A, N253A, H348A, H385A and H387A) were determined against p-NPP (yellow
bars) or bis-(p-NPP) (violet bars) as substrates. The dot line indicates the phosphatase and phosphodiesterase basal activities of soluble fraction of proteins from
M. smegmatis wild type as negative control.
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FIGURE 3 | Rv2577 participates in the arrest of human phagosome maturation. (A) Human THP-1 macrophages were infected with M. tuberculosis wild type (Mtb),
the Rv2577 mutant (Rv2577-mut) and the complemented (Rv2577-comp) strains to analyze the intracellular trafficking. The bacteria were labeled with FITC (green)
and the LAMP-3 protein was detected using a specific antibody (red). (B) Quantification of the fluorescence observed in (A) (association of LAMP-3 to the
mycobacterial compartment). The data are based on a representative experiment of three independent experiments, all performed in duplicate. ***p < 0.001,
**p < 0.01 statistical analysis using ANOVA. Number of counted phagosomes = 150 from at least 50 different macrophages.
survival of the three strains in human THP-1 macrophages
(Supplementary Figure 10).
These results indicate that the Rv2577 gene is expressed at
early time of macrophage infection and suggest that the Rv2577
protein have a role in the modulation of phagosome maturation
exerted by Mtb during macrophage infection.
Rv2577 Is Relevant for Mtb Replication in
Mice
An analysis of the bacterial loads of the Mtb wild type,
Rv2577 mutant and complemented strains in BALB/c mice
intratracheally infected with either of these strains revealed a
significant decrease in the colony forming units (CFU) in lungs
for the Rv2577 mutant, relative to the wild type or complemented
strains, after 30 days post-infection (Figure 4A). Similarly, CFUs
in the spleen of mice infected with the Rv2577 mutant were
significantly reduced in comparison to the wild type (Figure 4B).
However, the complemented strain failed to restore the wild
type virulence, thus suggesting a possible loss of the replicative
plasmid expressing Rv2577 during spleen infection. In fact, the
growth of the complemented strain was strongly compromised in
hygromycin containing media (resistance given by the plasmid)
after infection. This finding suggests that the bacteria lost the
plasmid by some still unknown mechanism. Likely, the absence
of antibiotic in the in vivo environment impaired the selection of
recombinant mycobacteria, thus affecting their survival capacity.
Altogether, Rv2577 mutant has an impaired replication in
mice; which suggests that Rv2577 has a role in Mtb virulence.
DISCUSSION
In this study we detected two isoforms of Rv2577 expressed
in M. smegmatis: one of low MW detected in the soluble
fraction (which includes proteins from the inner membrane
and the cytoplasm) and another, more abundant, of high MW,
which reaches the cell wall. This result probably reflects the
transit of Rv2577 from the cytosol, where it is synthesized,
to the cell wall. The absence of this protein in the culture
supernatant of M. smegmatis may indicate that Rv2577 is
a protein anchoring to the wall, where it probably acts as
a phosphatase/phosphodiesterase enzyme. In this line, mPDE
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FIGURE 4 | The Rv2577 mutation attenuates M. tuberculosis virulence in mice. The bacterial loads of M. tuberculosis wild type (Mtb), Rv2577 mutant (Rv2577-mut)
and the complemented (Rv2577-comp) strains were measured as colony forming units (CFU*ml-1) in the lungs (A) or spleen (B) of BALB/c mice at 1 and 30 days
post-infection (dpi). All strains showed similar pulmonary bacillary load at 1dpi. The values are expressed as the mean ± SD. of CFUs for mouse organs (n = 6).
***p < 0.0001, **p < 0.001 calculated using ANOVA test.
expressed in M. smegmatis is mainly located in the cell wall
(Chakraborti, 2016) and this location is promoted by the negative
charges that confer phosphorylation by an eukaryote-like Ser/Thr
kinases (Chakraborti, 2016; Malhotra et al., 2017).
Traini et al. (2017) have found that N-glycosylation
occurs in the sphingomyelin phosphodiesterase acid-Like 3A
(SMPDL3A), a member of Calcineurin-like phosphodiesterase.
This modification is essential for protein secretion and for the
inhibition of its degradation in the proteasome (Traini et al.,
2017). We were unable to demonstrate any phosphorylation or
glycosylation in Rv2577 by nano-HPLC-MS/MS analyses.
Further characterization of Rv2577 is indispensable to
understand the existence of the apparent two forms of this
protein in the cell wall.
Rv2577 has both phosphatase and phosphodiesterase activities
against artificial substrates. Unlike most eukaryotic PAPs (Schenk
et al., 2005), although similarly to those of prokaryotic organisms
(Shenoy et al., 2005; Yeung et al., 2009; Rodriguez et al.,
2014), purified rRv2577 showed optimal activity at alkaline
pH, with lower activity at acidic pH. In addition, the similar
specificity constant kcat/Km for p-NPP or bis-(p-NPP) suggests
that the physiological substrate is a monophosphate ester or/and
phosphodiester substrate. The Km value of Rv2577 for p-NPP
(80 µM), which can give an idea of the affinity for the substrate,
was similar to that observed for the archetypical PAP 1xzw from
I. batatas (Km = 68 µM) (Schenk et al., 2005) and for PhoD
from Bacillus subtilis (Km = 50 µM)(Rodriguez et al., 2014).
However, this parameter was four times lower than that of the
PAP from Burkholderia cenocepacia (Km = 330 µM) (Yeung
et al., 2009). Regarding the Vmax for p-NPP, all these enzymes
showed a superior catalytic activity than Rv2577. The Vmax of
Rv2577 (Vmax = 0,042 µmol p-NP∗min−1∗mg protein−1), on the
other hand, was similar to that reported for mPDE from Mtb
(Vmax = 0,017 µmol p-NP∗min−1∗mg protein−1) (Shenoy et al.,
2005). In contrast to Rv2577, mPDE has a clear better activity
against bis-(p-NPP) (Shenoy et al., 2005), with a specificity
constant 10 times higher than the value determined for Rv2577
(kcat/Km = 0,192 min−1µM−1 vs. 0,017 min−1µM−1) (Shenoy
et al., 2005). However, it is important to note that Rv2577
has a better affinity for bis-(p-NPP) (60 µM) than mPDE (Km
1,300 µM).
These values could suggest that, in the contexts of the
bacterium, Rv2577 acts when a low concentrations of
phosphodiester substrates is presented in the medium, whereas
mPDE becomes the best enzyme when the concentration of this
substrate is increased.
Regarding physiological substrates, mPDE is more active
toward phosphodiester compounds as the second messengers
3′,5′-cyclic AMP and cyclic-GMP (Shenoy et al., 2005) and
2′,3′-cAMP (Keppetipola and Shuman, 2008). Interestingly, the
Mtb genome contains 13 genes for adenylyl cyclases, being
mPDE the unique PDE that allows the maintenance of a
correct cAMP homeostasis in the bacterium (Johnson and
McDonough, 2018). In addition, YmdB from B. subtilis has
the same structure domain and kinetic characteristic than
mPDE and both enzymes share the same catalytic activity
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toward 3′,5′-cyclic AMP/cGMP and their preference for 2′,3′-
cAMP and 2′,3′-cGMP compounds (Diethmaier et al., 2014).
Thus, we can hypothesize that Rv2577 has a similar action
against 3′,5′-cyclic AMP or cyclic-GMP substrates and that it
fulfills a role in cAMP homeostasis. However, further studies
are essential to assess this putative role, as the demonstrated
activity toward the evaluated artificial substrates has not allowed
us to conclude the precise physiological substrates of the
enzyme. Thus, we cannot rule out that Rv2577 acts on other
types of phosphorylated substrates, since a calcineurin-like
phosphoesterase domain is also present in a large superfamily.
This superfamily includes PAPs (Schenk et al., 2005; Yeung
et al., 2009), PDEs (Shenoy et al., 2005; Diethmaier et al.,
2014; Rodriguez et al., 2014), phosphoprotein phosphatases
(PPPs), Mre11-SbcD DNA repair enzymes (Williams et al.,
2008), Dbr1-like RNA debranching enzymes (Wang et al.,
2013), YbbF-like UDP-2,3-diacylglucosamine hydrolases and
acid sphingomyelinases (ASMases) (Flores-Díaz et al., 2016). The
variety of substrates observed in this superfamily suggests that
Rv2577 has a wide range of possible physiological substrates.
Rv2577 conserves the catalytic site structure of PAPs, which is
similar to that of PDEs: the octahedral architecture of aspartic,
histidine and asparagine in their active site. This suggests
a similar catalytic mechanism with a binuclear metal center
essential for catalysis (Richter, 2002). Mutations in any of the
active site residues completely abrogated the in vitro enzymatic
activities of Rv2577. According to this finding and to the
molecular model of Rv2577, the residues D173, D217, Y220, and
H387 in the active site could coordinate the iron metal, whereas
the residues N253, H348 and H385 could coordinate manganese
and finally the D217 residue could coordinate the oxygen Fe – O –
Mn bridge.
Furthermore, the molecular model of Rv2577 allows us to
hypothesize that Rv2577 has a binuclear active center similar
to the archetypical PAP 1xzw from I. batatas (Schenk et al.,
2005) or the PDEs mPDE from Mtb (Shenoy et al., 2007)
and YmdB from B. subtilis (Diethmaier et al., 2014). However,
Rv2577 would be different from the PAP PhoD from B. subtilis,
which has an active site consisting of three metal, one iron
and two calcium atoms (Rodriguez et al., 2014). This is
because the residues D265 and N271-N272, which coordinate the
second calcium atom in the PhoD active site, are not equally
conserved in Rv2577; instead they have the G252, V258, and G259
amino acid residues.
Even when PAPs and PDEs share the same active site
architecture, the presence of a tyrosine is typical of PAPs, such as
1xzw (Schenk et al., 2005) and PhoD (Rodriguez et al., 2014). This
amino acid, by contrast, is absent in PDEs (Richter, 2002) such as
mPDE (Shenoy et al., 2007) and YmdB (Diethmaier et al., 2014).
Indeed, the Y220 residue in the active site of Rv2577 suggests that
monophosphoesters are better target substrates for this enzyme.
In this study, Rv2577 showed to be essential for the full
replication of Mtb in mice, at least in the infection model herein
evaluated. As reported for several Mtb phosphatases such as
PtpA, PtpB, and SapM (Singh et al., 2003; Beresford et al.,
2007; Wong et al., 2011; Wong et al., 2013; Forrellad et al.,
2013b), the contribution of Rv2577 to the in vivo persistence
of Mtb could be, in part, to favor the arrest of phagosomes
containing mycobacteria in non-lytic and non-acidic endosomal
compartments. Rv2577 could be active in these environment
conditions, as evidenced by its better in vitro catalytic activity at
physiological and alkaline pHs.
However, the role of phosphatases in the virulence
mechanisms of Mtb does not seem to be only limited to
modulating phagosomal traffic. In this sense, PtpB promotes
the decrease of pERK1/2 and p38 phosphorylated proteins,
thus leading to lower levels of IL-6, iNOS suppression and
IL-1β expression. All this, in turn, leads to a decrease in the
inflammatory response of the host. In addition, PtpB increases
phosphorylated Akt, which decreases the apoptotic activity of the
macrophage (Wong et al., 2013; Fan et al., 2018).
On the other hand, a recent study has reported that PtpA,
the most characterized Mtb phosphatase, regulates host gene
transcription by binding to specific nuclear DNA regions (Wang
et al., 2017). In the case of PDE, CdnP has a dual action
that allows the maintenance of adequate levels of cAMP in the
bacterium and cGAMP in the host. This leads to inhibition
of the bactericidal response mediated by type I IFN and the
activation of STING (Dey et al., 2017). This finding uncovers
novel aspects of phosphatases and PDE activities in mycobacteria,
and emphasizes the importance of these enzymes in the host-
pathogen interactions of tuberculosis infections.
In summary, in this study we demonstrated that Rv2577 is
relevant for the replication of Mtb in mice possibly because of
its phosphatase and phosphodiesterase activities. Rv2577 is the
first high molecular weight enzyme reported in Mtb with both
phosphatase and phosphodiesterase activities in vitro. Because
of this, we suggest a new name for Rv2577: mapH/MapH for
mycobacterial alkaline phosphatase/phosphodiesterase.
Further studies involving the assessment of potential natural
substrates of Rv2577 are necessary to better understand the role
of this enzyme in the physiology of Mtb and in its participation in
the interaction of the bacteria with the host.
MATERIALS AND METHODS
Bacterial Strains and Culture Media
M. tuberculosis CDC 1551 wild type (Mtb), Rv2577 mutant
(Rv2577-mut) and the complemented (Rv2577-comp) strains
were grown in Middlebrook 7H9 medium (Difco Laboratories)
supplemented with albumin 0.5%, dextrose 0.4%, Tween 80
0.05% and glycerol 0.5% (7H9-AD-T-G) or Middlebrook 7H10
(Difco Laboratories) supplemented with AD-T-G (7H10-AD-
T-G). M. smegmatis strain ATCC 700084 mc2155 was grown
in 7H9 or 7H10 medium supplemented with pyruvic acid
sodium salt 0.4% (P) and tyloxapol 0.05%. Albumin was omitted
from the media when preparing cultures for protein expression
and purification. Antibiotics were added to the media as
follows: 50 µg/ml hygromycin and 20 µg/ml kanamycin for
mycobacterial growth or 200 µg/ml hygromycin, 100 µg/ml
ampicillin and 50 µg/ml kanamycin for E. coli growth.
BEI Resources kindly donated the strains: Mtb CDC 1551 wild
type and the Mtb CDC 1551 MT2654 mutant in the MT2654
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gene, the ortholog to Rv2577 gene in Mtb H37Rv. This mutant
strain was named Rv2577 mutant or Rv2577-mut, since it is the
same gene (Supplementary Table 2). Rv2577-mut is an Mtb CDC
1551 background strain with a Himar1 transposon insertion in
the MT2654 gene (the Rv2577 gene ortholog). The lack of the
intact Rv2577 gene ortholog in Rv2577-mut was confirmed by
PCR using the nptII (CAGACAATCGGCTGCTCTGAT) and
low nptII (TGCGATGTTTCGCTTGGTGGT) set of primers to
detect the KmR insertion and FwRv2577Ms and RevRv2577Ms
set of primers (Supplementary Table 2) to detect the Rv2577
wild type gene. The Mtb Rv2577 mutant was complemented
with the replicative pVV16-Rv2577 plasmid carrying the
Rv2577 gene amplified from the Mtb CDC 1551 chromosome
with the FwRv2577 (5′CATATGGTGGGCGCCGATCTG3′)
and RevRv2577 (5′CATATGTATCCGCCGCGCGGC3′) set of
primers and cloned in a NdeI restriction sites into the pVV16
vector (Supplementary Table 2).
The in vivo virulence experiments in mice, the ex vivo
experiments in macrophages and cellular trafficking assays were
performed with the Mtb strains cultured up to late exponential
growth phase. The bacteria were harvested at 4,000 rpm for
10 min, washed and suspended in phosphate buffer saline
(PBS). The bacterial suspensions were passed through a syringe
needle (25 gauge) 30 times to disaggregate bacterial clumps,
and then centrifuged at 1,000 rpm for 8 min to remove the
clumps. The OD600 nm was used as measure of bacterial density,
where OD = 0.1 represents 1∗107bacterium/ml, to subsequently
calculate the multiplicity of infection (MOI). Infective doses were
determined by bacterial counting in a Neubauer camera before
BacLight staining.
Expression and Purification of Rv2577
Enzyme
The Rv2577 gene was amplified by PCR from the Mtb
chromosome using the FwRv2577Ms and RevRv2577Ms set of
primers (Supplementary Table 2). A fragment band of 1590 bp
was purified from the agarose gel and cloned into pGEM R©-T Easy
vector (Promega). Recombinant pGEM R©T-Easy::Rv2577 was
selected and restricted by NdeI/EcoRV restriction enzymes. The
resulting fragment of ∼1.6 kb of the Rv2577 gene was subcloned
in the same NdeI/EcoRV site into the pML2031 plasmid. The
recombinant pML2031::Rv2577 vector with the correct sequence
was selected and used to electroporate M. smegmatis mc2155.
The Rv2577 protein was expressed in the homologous host
M. smegmatis from the pML2031::Rv2577, which allows its
expression as a recombinant protein containing hemagglutinin
(HA) and histidine (His) tags (rRv2577). M. smegmatis
(pML2031::Rv2577) was grown at 37◦C until an OD600 nm = 1.
The expression was induced by the addition of isovalernitrile
(IVN) 500 µM and by culturing the bacteria overnight (ON) at
16◦C and 150 rpm.
The cell wall fraction (CWF) as well as the soluble
cytoplasm and membrane proteins fractions (SF) were obtained
as previously described (Forrellad et al., 2014) with some
modification. The enrichment in membrane associated proteins
was improved by suspending the cells in lysis buffer containing
CHAPS (Tris-Cl 50 mM pH 8, NaCl 150 mM, Glycerol 10%,
CHAPS 20 mM) as detergent. Then, the cells were treated with
lysozyme (1 mg/ml) for 30 min at 4◦C, mechanically lysed by
Precellys homogenizer and then treated with DNasa (2 µg/ml)
for 15 min at 4◦C. Subsequently, the cell extract was centrifuged
at 6,000 rpm for 20 min at 4◦C and the supernatant was collected
and centrifuged for a second time at 13,000 rpm for 1 h at
4◦C. The supernatant contains the proteins from the SF, whereas
the pellet contains the proteins from the CWF. The proteins
were separated by 12% SDS-PAGE and Coomassie brilliant blue
stained. Detection of rRv2577 was evaluated by Western blotting
using the monoclonal α-HA (Sigma) as primary antibody and
the α-IgG-mouse conjugated to Alkaline phosphatase (Sigma)
as secondary antibody. The antigen-antibody complex was
revealed by BCIP/NBT (Promega) reaction performed in alkaline
phosphatase buffer.
The molecular weight of Rv2577 was determined performing
an Rf vs. Log MW curve, by using the unstained LMW-SDS
marker (GE Healthcare) from a 12% SDS-PAGE followed by
Coomassie brilliant blue staining. The prestained Blue Plus R©
Protein Marker (TransGen Biotech) was also included in the gel.
The protein rRv2577 from the soluble fraction was purified
by affinity chromatography using an IMAC-Ni+2-agarose resin
(Qiagen) previously equilibrated in lysis buffer. The recombinant
HA-His-tagged protein was eluted whit the same buffer
containing 250–500 mM imidazole and then dialyzed against
lysis buffer without CHAPs and imidazole. Protein concentration
was calculated by Bradford reagent (Bradford, 1976). The SF and
CWF obtained from M. smegmatis wild type and the recombinant
M. smegmatis carrying the empty pML2031 vector were used
as negative controls as a measured of basal phosphatase and
phosphodiesterase activities in mycobacteria.
Phosphatase Activity
The phosphatase and phosphodiesterase activities were assayed
at 37◦C in an activity buffer (100 mM Tris-HCl 8 pH, 2 mM
MgCl2) using the artificial p-nitrophenyl phosphate (p-NPP)
(Sigma-Aldrich SRE0026) or bis-p-nitrophenyl phosphate [bis-
(p-NPP)] (Sigma-Aldrich N3002), respectively, and at a final
volume of 200 µl. The enzymatic activity in SF and in the purified
rRv2577 was evaluated by adding 100 µg and 1 µgr of the protein,
respectively. After 60 min of incubation, the dephosphorylation
was monitored by recording the increase of absorbance at 405 nm
of p-NP. The activity was expressed as ηmol p-NP∗min−1∗mg of
protein−1 using calibrate curves performed with 0, 2, 4, 6, 8, 12,
16 and 20 nmol of p-NP in buffers 100 mM MES 6 pH, 100 mM
HEPES 7.5 pH and 100 mM Tris-ClH 8 and 9 pH. The same set
of buffers was used to determine the optimum pH of rRv2577
activity against the p-NPP and bis-(p-NPP).
Kinetic parameters were determined under v0 conditions
and at a range of substrate concentrations of 0.1–10 mM
of p-NPP and bis-(p-NPP) was used. The kinetic constants
Km and Vmax were calculated using the best fitting curve
to the Michaelis-Menten equation by Non-linear regression –
Michaelis-Menten in GraphPad Prim 7.0. The kcat was calculated
with the equation kcat = Vmax/Eo, with Vmax values as ηM
p-NP min−1 and Eo as ηM of rRv2577. Control reactions
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without substrates or the enzyme were included to measure the
background level of phosphate. All assays were performed at
least in triplicate.
Nano-HPLC-MS/MS Analysis
The presence of Rv2577 in the SF, CWF and supernatant
culture was determined by nano-HPLC-MS/MS. The protein
fractions containing 40 µg of proteins were separated by 12%
SDS-PAGE followed by staining with Coomassie brilliant blue
and Western blotting using the α-HA antibody. Proteins from
the supernatant were precipitated by 10% TCA (trichloroacetic
acid) treatment at 4◦C for O/N, centrifuged at 13,000 rpm
and the pellet suspended in Laemmli SDS sample buffer before
performing SDS-PAGE. The line from the gel corresponding
to each sample of protein was cut in three segments; Cys
residues were reduced and alkylated with iodoacetamide and
then a gel digestion with trypsin was performed as described
previously (Gil et al., 2019). Tryptic peptides were separated
using a nano-HPLC system (UltiMate 3000, Thermo Scientific)
fitted with a reverse phase nano-column (PepMap RSLC C18,
50 cm × 75 µm ID, 2 µm, Thermo Scientific) and coupled
online with a hybrid quadrupole-Orbitrap mass spectrometer
(Q-Exactive Plus, Thermo). A linear gradient of solvent B
[acetonitrile, 0.1% formic acid (v/v)] from 5 to 55% in 120 min
was used. The mass spectrometer was operated in data-dependent
acquisition mode. MS/MS of top 12 signals were acquired using a
dynamic exclusion list.
A target decoy database was constructed with sequences from
M. smegmatis strain ATCC 700084/MC2155 downloaded from
Uniprot and containing Rv2577 sequence and the 127 most
common proteomic contaminants. Patternlab for proteomics
platform was used from protein identification by database search
(FDR < 1% at protein level) (Carvalho et al., 2016). Trypsin
was set as the proteolytic enzyme; cysteine carbamidomethylation
and methionine oxidation were set as fixed and variable
modifications, respectively. Additional searches were performed
using the following post-translational modifications: pupylation
(K); phosphorylation (S, T, Y); and glycosylation on S,
T, and N (DeoxyHex; Hept; Pent; Hex; HexNac; HexN;
MurNGlyc; MurNac).
The mass spectrometry proteomics data have been deposited
to the ProteomeXchange Consortium via the PRIDE (Perez-
Riverol et al., 2019) partner repository with the dataset
identifier PXD019769.
In silico Analysis, Structural
Characterization, and Site-Directed
Mutations
In silico analyses of Rv2577 primary sequences were performed
using the UniprotKB/Swiss-prot database and the protein-
protein BLAST algorithm with the parameter values by default.
Conserved Domain Database (CDD) and Pfam in the NCBI
and PROSITE in ExPASy were used to identify the conserved
domains in Rv2577.
The molecular structure model of Rv2577 was developed with
the i-tasser server based on multiple crystallographic structures
of related phosphatases. This analysis yielded the PAP from
I. batatas (protein data bank code; PDB: 1XZW) as the most
similar structural analog. The ConSurf server was used to
estimate the evolutionary conservation of amino acid residues,
by aligning 150 analog proteins of alkaline and acid phosphatases
from prokaryotic and eukaryotic organisms, respectively.
The functional and ligand analyses were performed with
the COACH predictor [within i-tasser (Yang and Zhang,
2015), by comparisons with the interaction complexes in
PDB]. The typical consensus catalytic motif of PAPs and PDEs
(GDXX/GDXXY/GNH [D/E]/XXXH/GHXH) is conserved
in Rv2577 in the residues D173/D217/Y220/N253/H348/H385
and H387. The Site-Directed Mutagenesis Instruction
Manual (Stratagene) was used as a guide in order to site-
directed mutation methodology to replace the codons for
D173/D217/Y220/N253/H348/H385 and H387 catalytic residues to
those that codify for alanine (Ala).
The vector pML2031::Rv2577 was used as a template and
specific primers carrying the mutant codons were designed
(Supplementary Table 2). The methylated parental DNA, which
carries the wild type sequence of Rv2577, was digested with
the enzyme DpnI (Promega) and the newly synthesized mutant
vectors were electroporated into M. smegmatis. Rv2577 wild
type proteins and site-directed mutants were overexpressed
and purified as HA-His fusion proteins. The phosphatase and
phosphodiesterase activities of the recombinant proteins were
evaluated with p-NPP and bis-(p-NPP) substrates, respectively,
as described above.
Rv2577 Gene Expression, RNA
Extraction and RT-PCR
The Rv2577 gene expression was determined in vitro during
the growth culture of Mtb CDC 1551 strain in rich 7H9-AD-T-
G media. The bacterium was cultured to exponential phase of
ÕD600 nm0.3–0.5. Reached this point, total RNA was obtained as
described by Santangelo et al. (2002).
In vivo expression of Rv2577 was determined during the
intracellular growth of Mtb CDC 1551 strain after 5 h of infection
of human THP-1 macrophages. Total RNA was obtained as
previously described (Blanco et al., 2009). cDNA was obtained
using 1 µg (in vitro) or 300 ηg (in vivo) of total RNA and reverse
transcribed using the M-MLV reverse transcriptase (Promega).
The Rv2577 expression was determined by end point PCR (RT-
PCR) using the Rv2577 F (5′ATTGCGATCGAGCGTATTGC3′)
and Rv2577 R (5′AATTCGGTCTTGTGCCAGGT3′) pair of
primers as described by Blanco et al. (2009). The expression of




The Mtb CDC 1551 wild type, Rv2577 mutant and complemented
strains (Supplementary Table 2) were covalently stained with
fluorescein isothiocyanate (FITC) (Sigma-Aldrich, 3326-32-7)
as previously described (Forrellad et al., 2013a). The stained
bacteria were used to infect human THP-1 or murine J774
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macrophages. Before infections, THP-1 cells were activated
by phorbol 12-myristate 13-acetate (PMA) treatment, 20 nM
for 48 h. Both macrophage cell lines were infected at a
MOI of 5:1 (bacterium:macrophage) and incubated in RPMI
medium for 1 h at 37◦C under a 5% CO2 atmosphere
(uptake). The infected macrophages were washed to eliminate
the extracellular bacteria and incubated for 2 h (chase).
Indirect immunofluorescence was performed on the infected
cells as previously described (Forrellad et al., 2013a). THP-
1 macrophages were marked using anti-LAMP-3 (Santa Cruz
Biotechnology, Inc.) (1:50 diluted in PBS), as primary antibody,
and anti-goat Cy5-conjugated (1:500 diluted in PBS), as
secondary antibody (Jackson Immuno Research Inc.). On the
other hand, J774 macrophages were marked using anti-LAMP-
2, as primary antibody, (the Developmental Studies Hybridoma
Bank, developed under the auspices of the NICHD and
maintained by The University of Iowa, Department of Biology,
Iowa City, IA 52242) and anti-rat Cy5-conjugated (Jackson
Immuno Research Inc.), as secondary antibody.
The cells were analyzed by confocal microscopy using a Leica
TCS-SP5 spectral confocal microscope (Leica Microsystems)
at the integrated Microscopy Laboratory (INTA Castelar,
Argentina). Mycobacterial internalization was analyzed and
quantified using Fiji software (U.S. National Institutes of Health,
Bethesda, MD) as described previously (Forrellad et al., 2013a).
The experiments were performed in duplicates and three
independent infections were performed for each assay.
The statistical analysis was performed using analysis of
variance (ANOVA) and Bonferroni’s post-tests. Fluorescence
intensity values were plotted and analyzed using GraphPad Prism
7 (GraphPad Software, Inc.).
Macrophage Infection
Human THP-1, stimulated by PMA treatment (as described
above), and murine J774 macrophages were infected with either
Mtb CDC 1551 wild type, Rv2577 mutant and complemented
strains (Supplementary Table 2) at a MOI of 0.1:1 and incubated
in RPMI medium for 1 h at 37◦C under a 5% CO2 atmosphere
(uptake). The infected macrophages were washed with PBS 1X
and incubated for 2 h (chase) in RPMI media supplemented
with 10 µg/ml gentamicin to eliminate the extracellular bacteria.
At 3, 48, 96, and 120 h post-infection (hpi) the bacteria were
collected, serial diluted and plated in 7H10-AD-G-T medium.
Colony formatting units (CFUs) were assessed after 30 days of
incubation at 37◦C.
Mouse Infection
BALB/c mice (6–8 weeks old, n = 6) were intratracheally
infected with Mtb CDC 1551 (wild type), Rv2577 mutant or
the complemented strains (Supplementary Table 2). For this
purpose, the bacteria were disaggregated and resuspended in PBS
buffer. The selected infective doses were 1∗103 bacteria/100 µl
of buffer per mouse. At 1 and 30 days post-infection (dpi), the
mice were sacrificed and the lungs and spleen were extracted,
homogenized and plated on 7H10-G-T-ADC solid medium to
determine the colony forming units (CFUs).
The experiments were performed in compliance with the
regulations of the Institutional Animal Care and Use Committee
(CICUAE) of INTA.
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Supplementary Figure 1 | Blastp alignment of Rv2577 protein. The sequence of
M. tuberculosis Rv2577 protein was used as query to perform a protein-protein
BLAST alignment by choosing UniprotKB/Swiss-prot database. The extent of the
alignment on the Rv2577 sequence is represented by color lines. The alignment
score between 80–200 (pink) and 50–80 (green) represented Purple acid
phosphatases (PAP) from eukaryote organisms: Glicyne max, Phaseolus vulgaris,
Ipomoea batatas, Arabidopsis thaliana, Allium cepa, and Dario rerio. The proteins
have an identity range from 28.88 to 22.39%. The conserved Purple acid
phosphatases N-terminal and MPP_superfamily of metallophosphatases or
Calcineurin-like phosphoesterase domains are located in residues 67–150 and
215–513 from Rv2577 sequence, respectively. Proteins with the worst extent
alignment score < 40 (black lines) are represented by a Probable
lactoylglutathione lyase and thymidylate synthase.
Supplementary Figure 2 | rRv2577 overexpressed in M. smegmatis occurs as
two isoforms. 12% SDS-PAGE of soluble (SF) (inner membrane and cytosolic) and
cell wall proteins (CWF) from M. smegmatis wild type (Ms), M. smegmatis carrying
the empty pML2031 vector (2031) and M. smegmatis carrying the recombinant
pML2031:Rv2577 vector (Rv2577) were transferred to a nitrocellulose membrane
and stained by Ponceau red staining (left panel). The same protein amount
(100 µg) was loaded per lane. The membrane was submitted to Western blot
using α-HA as primary antibody/α-IgG mouse∗alkaline phosphatase conjugated
as secondary antibody, and reveled with BCIP/NBT substrate (right panel). The
arrows show the rRv2577 isoform of 60.2 kDa from the soluble fraction (SF.
Rv2577) and the alternative 64.5 kDa protein from cell wall (CWF. Rv2577). MW.
Low Molecular Weight (LMW) SDS marker (GE Healthcare).
Supplementary Figure 3 | The rRv2577 activities are favored at alkaline pHs.
Phosphatase and phosphodiesterase activities of purified rRv2577 protein were
monitored at 6, 7.5, 8, and 9 pHs using p-NPP (circle) and bis-(p-NPP) (square)
substrates, respectively. rRv2577 presents a higher activity at physiological and
alkaline pH for both analyzed substrates.
Supplementary Figure 4 | Kinetic characterization of rRv2577. (A) Reaction
rates of rRv2577 using p-NPP (15 mM) as substrate showing the linear behavior
throughout the reaction time. In addition, the graph displays the enzyme activity
increase (slope of each curve) as a function of enzyme concentration present in
the assay, tested for 0 (circles), 0.5 (squares) and 1 µg (triangles) expressed as
ηmol of p-NP. (B) Michaelis-Menten kinetic representation of purified rRv2577
using p-NPP (circles) and bis-(p-NPP) (triangles) as substrates. The kinetic
constants Km and Vmax were calculated using the best fitting curve to the
Michaelis-Menten equation (Non-linear regression – Michaelis-Menten in
GraphPad Prim 7.0). Reaction rates of rRv2577 were expressed as specific activity
(ηmoles p-NP∗min−1∗mg−1 of protein). The kcat was calculated with the equation
kcat = Vmax/Eo, with Vmax values as ηM p-NP s−1 and Eo as ηM of rRv2577.
Supplementary Figure 5 | Expression of Rv2577 wild type and site-directed
mutants in M. smegmatis. Western blot analysis with α-HA antibody (top panel) of
the soluble (inner membrane and cytoplasm) (A) and cell wall (B) fractions of
proteins from M. smegmatis (Ms) and M. smegmatis overexpressing the Rv2577
wild type (Rv2577wt) or its site-directed mutants D173A, D217A, N253A, H385A,
Y220A, H348A, and H387A. The arrows indicate the presence of Rv2577. The
same protein amount (100 µg) was loaded per lane, as shown by Ponceau red
staining (bottom panel in A) and (B). Mw: Prestained Blue plus R© protein marker
14–100 kDa (TransGen Biotech) (A) or unstained LMW-SDS marker (GE
Healthcare) (B).
Supplementary Figure 6 | The integrity of the Rv2577 gene in the
M. tuberculosis strains. (A) PCR amplification of the kanamycin resistance (KmR)
from the genomes of M. tuberculosis CDC 1551 wild type (Mtb), Rv2577 mutant
(Rv2577-mut) and complemented (Rv2577-comp) strains. A4̃00 bp fragment of
the KmR was amplified from the Rv2577 mutant and complemented strains
(arrow). (B) PCR amplification of Rv2577 from the M. tuberculosis strains studied
in A); a 1590 bp fragment corresponding to the full Rv2577 gene was amplified
from the M. tuberculosis wild type and complemented strains (arrow). Mw: DNA
marker 1 kb (Roche). C+ : plasmid pML2031:Rv2577 was used as a
positive control.
Supplementary Figure 7 | Growth kinetics of the M. tuberculosis strains. Mtb
CDC 1551 (Mtb, black), Rv2577 mutant (Rv2577-mut, blue) and complemented
(Rv2577-comp, orange) strains were growth in 7H9 rich media as described in
section “Materials and Methods”. The bacterial growth kinetic was monitored by
OD600 nm measurement at different times (days). The data are representative of
three independent experiments performed in duplicate.
Supplementary Figure 8 | Rv2577 gene is transcribed during the in vitro and
in vivo growth of Mtb. (A) RT-PCR of Rv2577 gene in a 2% agarose gel
electrophoresis. Total RNA and cDNA were obtained from Mtb CDC 1551
bacterium growing in vitro into rich media (in vitro) or during its intracellular growth
after 5 h post-infection in human THP-1 macrophages (in vivo). The 81 bp
fragment corresponding to the Rv2577 gene is shown by the arrow (Rv2577). The
pML2031:Rv2577 vector (C+ p) and the genomic DNA from Mtb CDC 1551 strain
(C+) were used as positive controls. Water was used in the PCR mix as a negative
control (C−). (B) The 110 bp PCR fragment from the housekeeping sigA gene
(sigA, arrow) was used as a control of transcription. Mw: 100 bp DNA ladder
(TransGene Biotech).
Supplementary Figure 9 | Rv2577 participates in the arrest of murine
phagosome maturation. (A) Mouse J774 macrophages were infected with
M. tuberculosis wild type (Mtb) as well as the Rv2577 mutant (Rv2577-mut) and
the complemented (Rv2577-comp) strains to analyze the intracellular trafficking.
The bacteria were labeled with FITC (green) and LAMP-2 protein was detected
using a specific antibody (red). (B) Quantification of the fluorescence observed in
(A) the association of LAMP-2 to the mycobacterial compartment. The data are
based on a representative experiment of three independent experiments, all
performed in duplicate. ∗∗∗p < 0.001 statistical analysis using ANOVA.
Number of counted phagosomes = 150 from at least 50
different macrophages.
Supplementary Figure 10 | Ex vivo survival of M. tuberculosis strains in human
THP-1 macrophages. Survival of M. tuberculosis CDC 1551 wild type (Mtb),
Rv2577 mutant (Rv2577-mut) and complemented (Rv2577-comp) strains
measured as CFU∗ml−1 in human THP-1 macrophages after 3, 48, 96, and 120 h
post-infection (hpi). Data show a representative of three experiments performed
independently in duplicate. No significant differences were observed
by ANOVA analysis.
Supplementary Table 1 | Nano-HPLC-MS.MS analysis of Rv2577. Proteins
identified in soluble (line 3 to 126) and cell wall fraction (line 129 to 691) from M.
smegmatis expressing Rv2577. Proteins identified in supernatants from
M.smegmatis expressing Rv2577.
Supplementary Table 2 | Strains, plasmids and primers used in this study.
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